Advanced precancerous lesions within the GI tract: the molecular background.
about
The stomach in health and diseaseSquamous cell carcinoma antigen (SCCA) is up-regulated during Barrett's carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapyMultigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups.Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression.Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesisComprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis.Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis.Predictive proteomic biomarkers for inflammatory bowel disease-associated cancer: where are we now in the era of the next generation proteomics?The novel long noncoding RNA AC138128.1 may be a predictive biomarker in gastric cancer.Low expression of lncRNA-HMlincRNA717 in human gastric cancer and its clinical significances.Team work and cytopathology molecular diagnosis of solid pancreatic lesions.Early miR-223 Upregulation in Gastroesophageal Carcinogenesis.Noncoding RNAs as drivers of the phenotypic plasticity of oesophageal mucosa.Fhit down-regulation is an early event in pancreatic carcinogenesis.Immunotherapy in Gastrointestinal Cancers.Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer.High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers.Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastasesmiR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis
P2860
Q26784036-B501AAA5-32B7-4E86-B378-3570F242306FQ33648496-163923CB-7991-47EF-9A6E-E3AE092173ACQ33757122-C63F2C88-9D0F-47FD-B2BB-8DAD03DC346BQ34334326-D1F17133-FA04-40E9-8246-F959AF2EDD25Q34334539-7A5D2E8E-0445-4BA2-8B22-54DD21DC2E36Q36670779-FB5F8260-0FB6-4F5B-B5EB-7F8950035C23Q36782625-80BE5340-9919-445E-AC02-11706242DDFFQ38259539-26899D30-5318-4DE5-B888-12DA6A1075E2Q38952969-0E3E29B3-9980-464E-9D07-8772BB2D3E06Q38981653-4F2EC885-C166-40CA-9C68-CB4E86821031Q39132122-742785C2-BC4E-4D5A-A129-76CB5A2D2797Q40250083-7BCF23F9-8427-4B98-9C89-570D2061F646Q47132117-40F3E2CB-D58D-4E22-804E-9DE149749EB4Q48132427-ABD3FDB0-F932-4C3A-8EAA-91D0276CBFF6Q53183990-CB69B010-88A6-40B0-AAAE-F0EB7578F491Q54200101-3E5319CC-99CD-4C6B-A19F-61C6B5DDC92BQ54542254-A480F4DA-96CE-4D7F-8A15-DDD46278ABE5Q58761751-4A8F7B97-5F40-46D4-A79C-82EEB5052465Q59125292-BBCBBDA4-A63B-4B9A-9885-FDC8087A5ED4
P2860
Advanced precancerous lesions within the GI tract: the molecular background.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Advanced precancerous lesions within the GI tract: the molecular background.
@en
type
label
Advanced precancerous lesions within the GI tract: the molecular background.
@en
prefLabel
Advanced precancerous lesions within the GI tract: the molecular background.
@en
P1476
Advanced precancerous lesions within the GI tract: the molecular background
@en
P2093
András Kiss
Raffaele Baffa
P304
P356
10.1016/J.BPG.2013.03.009
P577
2013-04-01T00:00:00Z